BPI
IMCR icon

BFC Planning, Inc.’s Immunocore IMCR Stock Holding History

BFC Planning, Inc.’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-81
Closed -$2.44K – 3463
2026
Q1 		$2.44K Hold
81
– – ﹤0.01% 2545
2025
Q4 		$2.81K Hold
81
– – ﹤0.01% 2533
2025
Q3 		$2.94K Hold
81
– – ﹤0.01% 2358
2025
Q2 		$2.54K Hold
81
– – ﹤0.01% 2250
2025
Q1 		$2.4K Hold
81
– – ﹤0.01% 2257
2024
Q4 		$2.39K Buy
+81
New +$2.56K ﹤0.01% 2240

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BFC Planning, Inc.'s IMCR Position: Q2 2026 in Review

BFC Planning, Inc. sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 81 shares — an estimated $2.44K sold.

BFC Planning, Inc. first reported a position in IMCR in Q4 2024 and held it in 6 quarters. The position peaked at $2.94K in Q3 2025. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • BFC Planning, Inc. reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • BFC Planning, Inc. sold 81 Immunocore shares in Q2 2026, an estimated $2.44K.
  • BFC Planning, Inc. first reported a position in Immunocore in Q4 2024 and held it in 6 quarters.
  • BFC Planning, Inc.'s Immunocore position peaked at $2.94K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.